News Pyxis Oncology, Inc.

Equities

PYXS

US7473241013

Market Closed - Nasdaq Other stock markets 04:00:00 2024-04-18 pm EDT			5-day change	1st Jan Change
4.53 ^USD	-6.21%		-14.04%	+151.67%

Mar. 22	H.C. Wainwright Adjusts Price Target on Pyxis Oncology to $7 From $4, Maintains Buy Rating	MT
Mar. 21	Health Care Up on Drug Sales Optimism -- Health Care Roundup	DJ

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Pyxis Oncology : Stifel 2024 Virtual Targeted Oncology Forum	Apr. 16	PU
Pyxis Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)	Mar. 28	GL
Pyxis Oncology Obtains $8 Million Payment for the Sale of Royalty Rights	Mar. 27	GL
H.C. Wainwright Adjusts Price Target on Pyxis Oncology to $7 From $4, Maintains Buy Rating	Mar. 22	MT
Health Care Up on Drug Sales Optimism -- Health Care Roundup	Mar. 21	DJ
Pyxis Oncology Provides Corporate Update and Reports Financial Results for Fourth Quarter and Full Year 2023	Mar. 21	GL
Pyxis Oncology, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 21	CI
Pyxis Oncology Expands Board of Directors with Appointment of Santhosh Palani, Ph.D., CFA	Mar. 13	GL
Pyxis Oncology Expands Board of Directors with Appointment of Santhosh Palani, Ph.D., CFA	Mar. 13	AQ
Pyxis Oncology, Inc. Appoints Santhosh Palani to Its Board of Directors	Mar. 13	CI
Pyxis Oncology to Present at Leerink Global Biopharma Conference 2024	Mar. 07	GL
Pyxis Oncology to Present New PYX-201, PYX-106 and PYX-102 Preclinical Data at AACR Annual Meeting	Mar. 05	GL
Pyxis Oncology Announces Private Placement of Shares, Pre-Funded Warrants to Raise $50 Million	Feb. 27	MT
Pyxis Oncology Announces $50 Million Private Placement	Feb. 27	GL
Pyxis Oncology Announces $50 Million Private Placement	Feb. 27	AQ
Pyxis Oncology, Inc. announced that it expects to receive $49.999989 million in funding from Blue Owl Healthcare Opportunities, StemPoint Capital LP, Deep Track Capital, LP, Laurion Capital Management LP, Ridgeback Capital Management LLC and another investors	Feb. 25	CI
BTIG Initiates Pyxis Oncology With Buy Rating, $8 Price Target	Feb. 09	MT
Leerink Partners Initiates Coverage on Pyxis Oncology with Outperform Rating, $12 Price Target	Jan. 23	MT
Pyxis Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)	Dec. 29	GL
Pyxis Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)	Dec. 29	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Pyxis Oncology, Inc.

Equities

PYXS

US7473241013

Summary

Filters